CHICAGO--(BUSINESS WIRE)--ASCO Annual Meeting – Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the premier oncology digital therapeutic platform, today announced a ...
Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...
A new report offers insights from a multidisciplinary team of experts on intrahepatic cholangiocarcinoma (iCCA). Biomarker testing is becoming a prevalent component of treatment for patients with ...
MINNEAPOLIS – Health insurance must cover biomarker testing, which can help identify the right treatment plan for cancer and other conditions, under a new policy passed in the Minnesota Legislature ...
CHICAGO, ILLINOIS, UNITED STATES OF AMERICA, June 2, 2024 /EINPresswire.com/ -- Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback